Immplacate
New York
About Immplacate
Immplacate is a preclinical stage cell therapy company. To their knowledge, they are the first company to clinically develop educated mesenchymal cells (EMCs) for the treatment of unwanted immune responses.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Funding stage: Seed
- Last round: Pre-Seed (Jun 2020)
- Website: immplacatehealth.comenhome
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/immplacate-2458921 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.